ZyVersa Therapeutics Inc Sustainability Reports

ZyVersa Therapeutics Inc. develops innovative pharmaceutical therapies for the treatment of kidney disease and inflammatory disorders as a publicly traded biotechnology company.

Sector: Health Care

Country: United States

Exchange: OTC Markets

ISIN: US98987D3008

3 reports from 2022 to 2024

• ZyVersa Therapeutics Inc 2024 Annual Report on Form 10-K
• ZyVersa Therapeutics Inc 2023 Annual Report
• ZyVersa Therapeutics Inc 2022 Annual Report